A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.
Jun 4, 2024
0
43
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes ...
Jun 4, 2024
0
0
People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. The findings were present the at the annual meeting of the American Society of Clinical Oncology ...
May 29, 2024
0
0
A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall ...
May 24, 2024
0
2
A U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual disease (MRD), when evaluating proposed drugs to treat multiple myeloma.
May 22, 2024
0
2
Today is International Celiac Day. Celiac disease is a chronic autoimmune condition that occurs in around 1% of the world's population. It is triggered by the consumption of gluten proteins from wheat, barley, rye and some ...
May 16, 2024
0
31
The Children's Hospital Colorado's (Children's Colorado) Autoimmunity Screening for Kids (ASK) study has released its findings in support of mass screening for pediatric celiac disease. To date, there has been insufficient ...
May 13, 2024
0
0
New research presented at the European Congress on Obesity (ECO) in Venice, Italy (12–15 May), and published in the International Journal of Obesity, could help explain why type 2 diabetes is more common in men than in ...
May 10, 2024
0
2
For patients with solid tumors, assignment to an experimental group in trials of investigational drugs yields significant survival gains, according to a review published online April 30 in the Annuals of Internal Medicine.
Apr 30, 2024
0
0
For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology.
Apr 29, 2024
0
1
